Mechanistic explanations for counter‐intuitive phosphorylation dynamics of the insulin receptor and insulin receptor substrate‐1 in response to insulin in murine adipocytes

Insulin signaling through insulin receptor (IR) and insulin receptor substrate‐1 (IRS1) is important for insulin control of target cells. We have previously demonstrated a rapid and simultaneous overshoot behavior in the phosphorylation dynamics of IR and IRS1 in human adipocytes. Herein, we demonstrate that in murine adipocytes a similar overshoot behavior is not simultaneous for IR and IRS1. The peak of IRS1 phosphorylation, which is a direct consequence of the phosphorylation and the activation of IR, occurs earlier than the peak of IR phosphorylation. We used a conclusive modeling framework to unravel the mechanisms behind this counter‐intuitive order of phosphorylation. Through a number of rejections, we demonstrate that two fundamentally different mechanisms may create the reversed order of peaks: (i) two pools of phosphorylated IR, where a large pool of internalized IR peaks late, but phosphorylation of IRS1 is governed by a small plasma membrane‐localized pool of IR with an early peak, or (ii) inhibition of the IR‐catalyzed phosphorylation of IRS1 by negative feedback. Although (i) may explain the reversed order, this two‐pool hypothesis alone requires extensive internalization of IR, which is not supported by experimental data. However, with the additional assumption of limiting concentrations of IRS1, (i) can explain all data. Also, (ii) can explain all available data. Our findings illustrate how modeling can potentiate reasoning, to help draw nontrivial conclusions regarding competing mechanisms in signaling networks. Our work also reveals new differences between human and murine insulin signaling.

[1]  Jacob Roll,et al.  Systems biology: model based evaluation and comparison of potential explanations for given biological data , 2009, The FEBS journal.

[2]  Y. Zick,et al.  Uncoupling insulin signalling by serine/threonine phosphorylation: a molecular basis for insulin resistance. , 2004, Biochemical Society transactions.

[3]  L. Cantley,et al.  The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer. , 2005, Cell cycle.

[4]  P. Strålfors,et al.  Human, but not rat, IRS1 targets to the plasma membrane in both human and rat adipocytes. , 2007, Biochemical and biophysical research communications.

[5]  E. Schleicher,et al.  Interplay and effects of temporal changes in the phosphorylation state of serine-302, -307, and -318 of insulin receptor substrate-1 on insulin action in skeletal muscle cells. , 2008, Molecular endocrinology.

[6]  D. Leroith,et al.  Phosphorylation of Insulin Receptor Substrate-1 (IRS-1) by Protein Kinase B Positively Regulates IRS-1 Function* , 1999, The Journal of Biological Chemistry.

[7]  Peter Strålfors,et al.  Insulin resistance in human adipocytes occurs downstream of IRS1 after surgical cell isolation but at the level of phosphorylation of IRS1 in type 2 diabetes , 2004, The FEBS journal.

[8]  E. Schleicher,et al.  Protein Kinase C-ζ-induced Phosphorylation of Ser318 in Insulin Receptor Substrate-1 (IRS-1) Attenuates the Interaction with the Insulin Receptor and the Tyrosine Phosphorylation of IRS-1* , 2004, Journal of Biological Chemistry.

[9]  P. Strålfors,et al.  Rapid Insulin-Dependent Endocytosis of the Insulin Receptor by Caveolae in Primary Adipocytes , 2009, PloS one.

[10]  B. Kahn,et al.  Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. , 2006, The Journal of clinical investigation.

[11]  E. Van Obberghen,et al.  Molecular mechanisms of insulin receptor substrate protein‐mediated modulation of insulin signalling , 2003, FEBS letters.

[12]  P. Strålfors,et al.  Localization of the insulin receptor in caveolae of adipocyte plasma membrane , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  P. Strålfors,et al.  Cholesterol Depletion Disrupts Caveolae and Insulin Receptor Signaling for Metabolic Control via Insulin Receptor Substrate-1, but Not for Mitogen-activated Protein Kinase Control* , 2001, The Journal of Biological Chemistry.

[14]  P. Strålfors,et al.  Insulin-induced dephosphorylation of hormone-sensitive lipase. Correlation with lipolysis and cAMP-dependent protein kinase activity. , 1989, European journal of biochemistry.

[15]  P. Strålfors,et al.  Phosphorylation of IRS1 at serine 307 and serine 312 in response to insulin in human adipocytes. , 2006, Biochemical and biophysical research communications.

[16]  Y. Matsuzawa,et al.  Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3–kinase , 1999, Nature Genetics.

[17]  Mats Jirstrand,et al.  Systems biology Systems Biology Toolbox for MATLAB : a computational platform for research in systems biology , 2006 .

[18]  Jacob Roll,et al.  Model-Based Hypothesis Testing of Key Mechanisms in Initial Phase of Insulin Signaling , 2008, PLoS Comput. Biol..

[19]  L. Cantley,et al.  Then Negative Regulation of Phosphoinositide 3-Kinase Signaling by p85 and Its Implication in Cancer , 2005 .

[20]  Gunnar Cedersund,et al.  Mass and Information Feedbacks through Receptor Endocytosis Govern Insulin Signaling as Revealed Using a Parameter-free Modeling Framework* , 2010, The Journal of Biological Chemistry.

[21]  Peter Strålfors,et al.  Colocalization of insulin receptor and insulin receptor substrate-1 to caveolae in primary human adipocytes. Cholesterol depletion blocks insulin signalling for metabolic and mitogenic control. , 2004, European journal of biochemistry.